Willis Towers Watson Public Research and Development Expenses 2010-2025 | WTW

Willis Towers Watson Public annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Willis Towers Watson Public research and development expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Willis Towers Watson Public research and development expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Willis Towers Watson Public annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
  • Willis Towers Watson Public annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
  • Willis Towers Watson Public annual research and development expenses for 2022 were $0B, a 0% decline from 2021.
Willis Towers Watson Public Annual Research and Development Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Willis Towers Watson Public Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Finance Insurance Brokers $31.045B $9.930B
Willis Towers Watson plc is a leading global advisory, broking and solutions company. Willis Towers caters to the need of designs and delivers solutions that manage risk, optimize benefits, and expand capabilities, among others of large companies and mid-market and small businesses across the world. It reports through two operating segments: Risk & Broking, and Health, Wealth & Career.
Stock Name Country Market Cap PE Ratio
Marsh & McLennan (MMC) United States $103.438B 22.67
Arthur J Gallagher (AJG) United States $80.707B 30.54
Aon (AON) Ireland $80.522B 22.88
Hannover Ruck SE (HVRRY) Germany $38.118B 15.73
Brown & Brown (BRO) United States $29.637B 25.91
Ryan Specialty Holdings (RYAN) United States $17.386B 36.20
Erie Indemnity (ERIE) United States $16.431B 30.27
EToro Group (ETOR) Israel $5.331B 0.00
Tiptree Financial (TIPT) United States $0.808B 9.49
EHealth (EHTH) United States $0.116B 0.00
Huize Holding (HUIZ) China $0.027B 0.00
Oxbridge Re Holdings (OXBR) Cayman Islands $0.015B 0.00